All Reports

The global radiation therapy market is expected to reach US$13.28 billion in 2027, witnessing growth at a CAGR of 6.77%, over the period 2023-2027. Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing aging population and expanding urbanization are expected to drive the market. The growth of the market would be challenged by sever ..

China TAVR market is expected to reach US$2.60 billion in 2027, growing at a CAGR of 55.91%, for the duration spanning 2023-2027. While, the TMV market in China is forecasted to reach US$1832.05 million in 2027, rising at a CAGR of 146.50%, for the time period of 2023-2027. Factors such as growing prevalence of aortic stenosis, rise in approval of new TAVR products, rise in geriatric population ..

China online healthcare market is forecasted to reach US$426.39 billion in 2027, experiencing growth at a CAGR of 36.89% during the period spanning from 2023 to 2027. Growth in China online healthcare market is supported by factors such as aging population, rising health expenditure, support from Chinese government, technical innovations and rising internet penetration. However, the market grow ..

The global animal health market is expected to record a value of US$60.87 billion in 2027, growing at a CAGR of 6.30% for the period spanning 2023-2027. The factors such as growing middle class population, rising cattle/cow population, surge in demand for animal protein, rising U.S. expenditure on pets and growing  urbanization would drive the growth of the market. However, the market grow ..

The global plasma derived therapy market is anticipated to reach US$54.35 billion in 2027, growing at a CAGR of 7.20% during the period spanning 2023-2027. The growth in the market has been driven by factors like rising geriatric population, increasing prevalence of genetic disorders, government initiatives, rising demand for albumin, escalating use of plasma proteins in pharmaceuticals, increa ..

The US health expenditure is forecasted to reach US$6.07 trillion in 2027, experiencing growth at a CAGR of 5.61% during the period spanning from 2023 to 2027. The national health expenditure by source of funds can be segmented as follows: Managed care, Out of pocket, Investments and Others. In 2022, the dominant share was held by managed care segment. This was being followed by out of pocket, ..

The global RNAi therapeutics market is expected to record a value of US$1.26 billion in 2027, progressing at a CAGR of 10.02%, over the period 2023-2027. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associate ..

The China biological reagent market is forecasted to reach US$7.36 billion in 2027, experiencing growth at a CAGR of 14.99% during the period spanning from 2023 to 2027. Growth in the China biological reagent market was supported by factors such as increasing research in the field of life sciences, technological innovations, rising number of genome projects, rising incidence of genetic disorder ..

The global point of care diagnostics market is anticipated to reach US$40.43 billion in 2027, growing at a CAGR of 6.60% during the period spanning 2023-2027. The growth in the market has been driven by factors like rising global healthcare expenditure, rising geriatric population, escalating stress issues, increasing prevalence of chronic and infectious diseases, rising utilization of novel im ..

The global interventional pulmonology market is forecasted to reach US$4.95 billion in 2027, rising at a CAGR of 5.80%, for the time period of 2023-2027. Factors such as growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness would drive the growth of the market. Howev ..